SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people

The value of SARS-CoV-2 lateral flow immunoassay (LFIA) tests for estimating individual disease risk is unclear. The REACT-2 study in England, UK, obtained self-administered SARS-CoV-2 LFIA test results from 361,801 adults in January-May 2021. Here, we link to routine data on subsequent hospitalisat...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitaker, Matthew, Davies, Bethan, Atchison, Christina, Barclay, Wendy, Ashby, Deborah, Darzi, Ara, Riley, Steven, Cooke, Graham, Donnelly, Christl A., Chadeau-Hyam, Marc, Elliott, Paul, Ward, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432566/
https://www.ncbi.nlm.nih.gov/pubmed/37587102
http://dx.doi.org/10.1038/s41467-023-40643-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432566/
https://www.ncbi.nlm.nih.gov/pubmed/37587102
http://dx.doi.org/10.1038/s41467-023-40643-w

Ejemplares similares